Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Evoq Remedies's Enterprise Value is ₹254.72 Mil.
Evoq Remedies's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹20.48 Mil. Therefore, Evoq Remedies's EV-to-EBIT ratio for today is 12.44.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Evoq Remedies's Enterprise Value is ₹254.72 Mil.
Evoq Remedies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹20.56 Mil. Therefore, Evoq Remedies's EV-to-EBITDA ratio for today is 12.39.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Evoq Remedies's Enterprise Value is ₹254.72 Mil.
Evoq Remedies's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹85.02 Mil. Therefore, Evoq Remedies's EV-to-Revenue ratio for today is 3.00.
Evoq Remedies Enterprise Value Historical Data
The historical data trend for Evoq Remedies's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Evoq Remedies's Enterprise Value
For the Medical Distribution subindustry, Evoq Remedies's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evoq Remedies's Enterprise Value Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Evoq Remedies's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Evoq Remedies's Enterprise Value falls into.
Evoq Remedies Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Evoq Remedies's Enterprise Value for the fiscal year that ended in Mar. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evoq Remedies (BOM:543500) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Evoq Remedies's current Enterprise Value is ₹254.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Evoq Remedies's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was ₹20.48 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Evoq Remedies's current Enterprise Value is ₹254.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Evoq Remedies's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was ₹20.56 Mil.
Evoq Remedies's current Enterprise Value is ₹254.72 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Evoq Remedies's Revenue for the trailing twelve months (TTM) ended in Sep. 2023 was ₹85.02 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evoq Remedies Enterprise Value Related Terms
Thank you for viewing the detailed overview of Evoq Remedies's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Evoq Remedies Ltd is engaged in the pharmaceutical business involving marketing, trading and distribution of wide range of pharmaceutical formulation products such as anti-biotic drugs, calcium, multivitamins, injections and others. It operates in a single segment that is Pharmaceutical Trading.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:543500 has been successfully added to your